AcelRx Pharmaceuticals, Inc. (ACRX) - Earnings & Price History

ACRX: AcelRx Pharmaceuticals, Inc. - 1.975, $87.36M, 0.08 (3.95%)

Sector: Healthcare - Industry: Medical Appliances & Equipment

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The company's late-stage pipeline includes ARX-04, a 30 mcg sufentanil sublingual tablet which is designed for treatment of acute pain in medically supervised settings; and Zalviso (sufentanil sublingual tablet system), which is designed for management of moderate-to-severe acute pain in adult patients in the hospital setting. Its Zalviso delivers 15 mcg sufentanil sublingually through a non-invasive delivery route via a pre-programmed, patient-controlled analgesia device. Zalviso is approved in the European Union, as well as Norway, Iceland, and Liechtenstein; and is investigational and in late-stage development in the United States. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name

Past ACRX reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-02AMC-0.243.43.23.23.153.66.25%6.25%633.33K
2016-11-01AMC-0.232.72.83.22.623.214.29%▲-15.62%-3.57%241.90K
2016-07-28AMC-0.223.633.083.083.043.7317.86%17.86%1.21M
2016-05-02AMC-0.23.173.253.083.053.25-5.23%2.92%-2.46%299.06K
2016-03-07AMC-0.13.5543.813.513.85-4.75%-6.82%-11.25%626.47K
2015-10-29AMC-0.233.943.353.93.61416.42%▲1.03%17.61%3.60M
2015-08-03AMC-0.264.454.054.054.054.599.88%9.88%989.36K
2015-05-04AMC-0.283.0354.23.012.963.37-28.33%0.83%-27.74%2.84M
2015-03-09AMC-0.34.6455.515.184.635.18-5.99%-10.33%-15.70%3.06M
2015-03-03AMC-0.39.118.938.938.869.242.02%2.02%372.64K
2015-03-02AMC-0.38.939.139.138.9159.2-2.19%-2.19%361.71K
2014-11-10AMCAcelrx Pharmact-0.23-0.136.936.036.15.937.041.16%▲13.61%14.93%3.22M
2014-08-11AMCAcelrx Pharmact-0.27-0.346.146.456.46.086.5-0.78%-4.06%-4.81%1.36M
2014-05-08AMCAcelrx Pharmact-0.229.769.92109.510.190.81%-2.40%-1.61%554.70K
2014-03-03AMCAcelrx Pharmact-0.180.1812.2311.2411.9511.7912.446.32%2.34%8.81%1.34M
2013-11-05AMCAcelrx Pharmact-0.18-0.216.876.937.026.217.231.30%▲-2.14%-0.87%1.46M
2013-08-12AMCAcelrx Pharmact-0.25-0.229.6810.8210.829.6210.9-10.54%-10.54%1.55M
2013-05-08AMC-0.276.115.95.775.76.15-2.20%5.89%3.56%223.41K
2013-03-12-0.44.7854.994.994.715.1-4.11%-4.11%254.50K
2012-11-06AMC-0.382.752.92.722.272.948-6.21%▲1.10%-5.17%100.11K
2012-08-09AMCQ2 2012 AcelRx Pharm-0.39-0.3533.0732.953-2.28%-2.28%8.50K
2012-05-10Acelrx Pharmact-0.35-0.363.523.523.523.523.52
2012-05-08AMCQ1 2012 AcelRx Pharm-0.35-0.363.693.53.693.693.695.43%5.43%1.00K
2012-03-22Acelrx Pharmact-0.39-0.333.43.43.43.43.4
2012-03-20BMOQ4 2011 Acelrx Pharm-0.39-0.333.53.443.433.383.65-0.29%2.04%1.74%27.40K
2011-11-11Acelrx Pharmact-0.34-0.32.952.772.852.853.322.89%▲3.51%6.50%102.20K
2011-11-08BMOQ3 2011 Acelrx Pharm-0.34-0.32.782.92.92.782.9-4.14%-4.14%1.90K
2011-08-11BMOQ2 2011 Acelrx Pharm-0.32-0.253.73.63.783.73.965.00%-2.12%2.78%4.10K
2011-05-16AMCQ1 2011 Acelrx Pharm-0.22-0.33.683.653.693.653.751.10%-0.27%0.82%5.10K
2011-03-30AMCQ4 2010 Acelrx Pharm3.433.423.423.333.590.29%0.29%14.40K

Login | Register
Saturday Oct 20, 2018   EST
Enter a Ticker:

Economic Calendar

Existing Home Sales 10:00 AM ET Raphael Bostic speaks on Saturday 11:30 AM ET Raphael Bostic Speaks 12:00 PM ET Robert Kaplan Speaks 12:45 PM ET Baker-Hughes Rig Count 1:00 PM ET 

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades